OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cellular therapies: Day by day, all the way
Erden Atilla, Pelin Kılıç, Günhan Gürman
Transfusion and Apheresis Science (2018) Vol. 57, Iss. 2, pp. 187-196
Closed Access | Times Cited: 19
Erden Atilla, Pelin Kılıç, Günhan Gürman
Transfusion and Apheresis Science (2018) Vol. 57, Iss. 2, pp. 187-196
Closed Access | Times Cited: 19
Showing 19 citing articles:
Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions
Eline van Overbeeke, Sissel Michelsen, Mondher Toumi, et al.
Drug Discovery Today (2020) Vol. 26, Iss. 2, pp. 399-415
Open Access | Times Cited: 34
Eline van Overbeeke, Sissel Michelsen, Mondher Toumi, et al.
Drug Discovery Today (2020) Vol. 26, Iss. 2, pp. 399-415
Open Access | Times Cited: 34
Induced Pluripotent Stem Cells: The Most Versatile Source for Stem Cell Therapy
Marcie A. Glicksman
Clinical Therapeutics (2018) Vol. 40, Iss. 7, pp. 1060-1065
Open Access | Times Cited: 38
Marcie A. Glicksman
Clinical Therapeutics (2018) Vol. 40, Iss. 7, pp. 1060-1065
Open Access | Times Cited: 38
Stem cell therapy: old challenges and new solutions
Carmela Rita Balistreri, Elena De Falco, Antonella Bordin, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 4, pp. 3117-3131
Closed Access | Times Cited: 31
Carmela Rita Balistreri, Elena De Falco, Antonella Bordin, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 4, pp. 3117-3131
Closed Access | Times Cited: 31
Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
Robin Park, Fariha Eshrat, Mohammed Al‐Jumayli, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 447-447
Open Access | Times Cited: 26
Robin Park, Fariha Eshrat, Mohammed Al‐Jumayli, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 447-447
Open Access | Times Cited: 26
A new era of gene and cell therapy for cancer: a narrative review
Lin‐Fa Wang, Guangyang Liu, Libo Zheng, et al.
Annals of Translational Medicine (2023) Vol. 11, Iss. 9, pp. 321-321
Open Access | Times Cited: 8
Lin‐Fa Wang, Guangyang Liu, Libo Zheng, et al.
Annals of Translational Medicine (2023) Vol. 11, Iss. 9, pp. 321-321
Open Access | Times Cited: 8
Cost burden of diffuse large B-cell lymphoma
R. Andrew Harkins, Sharvil Patel, Christopher R. Flowers
Expert Review of Pharmacoeconomics & Outcomes Research (2019) Vol. 19, Iss. 6, pp. 645-661
Open Access | Times Cited: 22
R. Andrew Harkins, Sharvil Patel, Christopher R. Flowers
Expert Review of Pharmacoeconomics & Outcomes Research (2019) Vol. 19, Iss. 6, pp. 645-661
Open Access | Times Cited: 22
Leukocytapheresis in nonmobilized donors for cellular therapy protocols: Evaluation of factors affecting collection efficiency of cells
Joan Cid, Gloria Carbassé, Cristina Alba, et al.
Journal of Clinical Apheresis (2019) Vol. 34, Iss. 6, pp. 672-679
Closed Access | Times Cited: 15
Joan Cid, Gloria Carbassé, Cristina Alba, et al.
Journal of Clinical Apheresis (2019) Vol. 34, Iss. 6, pp. 672-679
Closed Access | Times Cited: 15
Progressing from transient to stable packaging cell lines for continuous production of lentiviral and gammaretroviral vectors
Jaeyoung Park, Sarah Inwood, Srivalli Kruthiventi, et al.
Current Opinion in Chemical Engineering (2018) Vol. 22, pp. 128-137
Open Access | Times Cited: 13
Jaeyoung Park, Sarah Inwood, Srivalli Kruthiventi, et al.
Current Opinion in Chemical Engineering (2018) Vol. 22, pp. 128-137
Open Access | Times Cited: 13
Where is human-based cellular pharmaceutical R&D taking us in cartilage regeneration?
Damla Alkaya, Cansu Gürcan, Pelin Kılıç, et al.
3 Biotech (2020) Vol. 10, Iss. 4
Open Access | Times Cited: 12
Damla Alkaya, Cansu Gürcan, Pelin Kılıç, et al.
3 Biotech (2020) Vol. 10, Iss. 4
Open Access | Times Cited: 12
Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use
Daniel S. Green, Ana Tablante Nunes, Kevin Tosh, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 12
Daniel S. Green, Ana Tablante Nunes, Kevin Tosh, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 12
Axicabtagene Ciloleucel (Yescarta)
CADTH
Canadian Journal of Health Technologies (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
CADTH
Canadian Journal of Health Technologies (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Quantification and characterization of granulocyte macrophage colony-stimulating factor activated human peripheral blood mononuclear cells by fluorine-19 cellular MRI in an immunocompromised mouse model
Corby Fink, Michael Smith, Olivia C. Sehl, et al.
Diagnostic and Interventional Imaging (2020) Vol. 101, Iss. 9, pp. 577-588
Open Access | Times Cited: 8
Corby Fink, Michael Smith, Olivia C. Sehl, et al.
Diagnostic and Interventional Imaging (2020) Vol. 101, Iss. 9, pp. 577-588
Open Access | Times Cited: 8
Idecabtagene Vicleucel (Abecma)
Reimbursement Team
Canadian Journal of Health Technologies (2022) Vol. 2, Iss. 2
Open Access | Times Cited: 5
Reimbursement Team
Canadian Journal of Health Technologies (2022) Vol. 2, Iss. 2
Open Access | Times Cited: 5
Lisocabtagene Maraleucel (Breyanzi)
CADTH
Canadian Journal of Health Technologies (2022) Vol. 2, Iss. 10
Open Access | Times Cited: 5
CADTH
Canadian Journal of Health Technologies (2022) Vol. 2, Iss. 10
Open Access | Times Cited: 5
Understanding factors affecting human chondrocyte culturing: an experimental study
Pelin Kılıç, Cansu Gürcan, Günhan Gürman, et al.
Cell and Tissue Banking (2020) Vol. 21, Iss. 4, pp. 585-596
Closed Access | Times Cited: 5
Pelin Kılıç, Cansu Gürcan, Günhan Gürman, et al.
Cell and Tissue Banking (2020) Vol. 21, Iss. 4, pp. 585-596
Closed Access | Times Cited: 5
Regulatory Environment and Approvals in Cell and Gene Therapy Products Between Japan, the USA, and the EU
Yuya Sato, Shunsuke Ono
Therapeutic Innovation & Regulatory Science (2022) Vol. 57, Iss. 2, pp. 227-237
Closed Access | Times Cited: 2
Yuya Sato, Shunsuke Ono
Therapeutic Innovation & Regulatory Science (2022) Vol. 57, Iss. 2, pp. 227-237
Closed Access | Times Cited: 2
Brexucabtagene Autoleucel (Tecartus)
Reimbursement Team
Canadian Journal of Health Technologies (2021) Vol. 1, Iss. 11
Open Access | Times Cited: 2
Reimbursement Team
Canadian Journal of Health Technologies (2021) Vol. 1, Iss. 11
Open Access | Times Cited: 2
Stem Cells and Psyche: Perspectives and a Review of the Literature
Hakan Kumbasar, Berker Duman, Meltem Kurt Yüksel, et al.
Journal of Oncological Sciences (2020) Vol. 6, Iss. 2, pp. 103-118
Open Access | Times Cited: 1
Hakan Kumbasar, Berker Duman, Meltem Kurt Yüksel, et al.
Journal of Oncological Sciences (2020) Vol. 6, Iss. 2, pp. 103-118
Open Access | Times Cited: 1
Tisagenlecleucel (Kymriah)
CADTH
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 11
Open Access
CADTH
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 11
Open Access
